ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
-2.18%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
(-32%)
Cap. Flow
-$40M
Cap. Flow
% of AUM
-38.87%
Top 10 Holdings %
Top 10 Hldgs %
59.56%
Holding
45
New
6
Increased
11
Reduced
10
Closed
15
Top Buys
| 1 |
Acadia Pharmaceuticals
ACAD
|
$7.56M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$6.52M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$2.9M |
| 4 |
Galapagos
GLPG
|
$2.82M |
| 5 |
Cartesian Therapeutics
RNAC
|
$2.51M |
Top Sells
| 1 |
Sanofi
SNY
|
$8.75M |
| 2 |
GSK
GSK
|
$7.51M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.05M |
| 4 |
Rocket Pharmaceuticals
RCKT
|
$6.93M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$5.16M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ultragenyx Pharmaceutical
RARE
$2.89B
| $8.58M | 8.35% | 185,261 -31,814 | -15% | -$1.47M |
|
|
WHWK
2
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $8.12M | 7.9% | 632,997 +508,372 | +408% | +$6.52M |
|
|
3
Acadia Pharmaceuticals
ACAD
$4.38B
| $7.56M | 7.35% | +474,741 | New | +$7.56M |
|
4
Mersana Therapeutics
MRSN
$36.5M
| $6.98M | 6.79% | 1,191,271 +259,732 | +28% | +$1.52M |
|
|
5
Galapagos
GLPG
$2.07B
| $6.22M | 6.05% | 140,054 +63,565 | +83% | +$2.82M |
|
|
ALLK
6
DELISTED
Allakos
ALLK
| $5.24M | 5.1% | 622,364 +24,192 | +4% | +$204K |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.84M | 4.71% | 37,639 -54,867 | -59% | -$7.05M |
|
|
8
Atea Pharmaceuticals
AVIR
$267M
| $4.63M | 4.5% | 962,694 +602,694 | +167% | +$2.9M |
|
|
SAGE
9
DELISTED
Sage Therapeutics
SAGE
| $4.54M | 4.42% | 119,008 +8,786 | +8% | +$335K |
|
|
AMRN
10
Amarin Corp
AMRN
$311M
| $4.51M | 4.39% | 3,730,859 -2,627,429 | -41% | -$3.18M |
|
|
11
Ironwood Pharmaceuticals
IRWD
$214M
| $4.04M | 3.93% | 326,428 -416,142 | -56% | -$5.16M |
|
12
Sana Biotechnology
SANA
$777M
| $4.01M | 3.9% | 1,015,273 +280,023 | +38% | +$1.11M |
|
13
Alkermes
ALKS
$4.78B
| $3.71M | 3.61% | 142,002 -157,998 | -53% | -$4.13M |
|
|
SYRS
14
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.12M | 3.03% | 868,403 | – | – |
|
15
Karyopharm Therapeutics
KPTI
$61.7M
| $3.05M | 2.97% | 896,618 -631,962 | -41% | -$2.15M |
|
16
Nektar Therapeutics
NKTR
$568M
| $3.02M | 2.93% | 1,334,661 +901,709 | +208% | +$2.04M |
|
|
17
Cartesian Therapeutics
RNAC
$261M
| $2.89M | 2.81% | 2,558,474 +2,224,219 | +665% | +$2.51M |
|
18
Biohaven
BHVN
$1.63B
| $2.49M | 2.42% | +179,085 | New | +$2.49M |
|
|
19
Rocket Pharmaceuticals
RCKT
$354M
| $2.45M | 2.38% | 125,176 -354,330 | -74% | -$6.93M |
|
|
MRTX
20
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.15M | 2.09% | +47,520 | New | +$2.15M |
|
21
Repligen
RGEN
$6.88B
| $2.06M | 2.01% | 12,180 -4,544 | -27% | -$769K |
|
22
ESSA Pharma
EPIX
$11.4M
| $2.05M | 1.99% | +811,555 | New | +$2.05M |
|
|
MDVL
23
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $1.77M | 1.72% | 5,894,897 | – | – |
|
24
Praxis Precision Medicines
PRAX
$958M
| $1.5M | 1.46% | +630,584 | New | +$1.5M |
|
|
MOR
25
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.45M | 1.41% | 405,602 +310,571 | +327% | +$1.11M |
|